BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 14504874)

  • 41. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Termination of mid-trimester pregnancy by transcervical extra-amniotic hypertonic saline method without in-dwelling catheter.
    Nummi S; Pystynen P
    Ann Chir Gynaecol Fenn; 1974; 63(6):479-82. PubMed ID: 4441028
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Stoutjesdijk JA; Alsma J; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal serum and amniotic fluid alpha-fetoprotein as a marker of acute fetal distress in a midtrimester abortion model.
    Weiss RR; Macri JN; Robins J; Elligers KW
    Obstet Gynecol; 1976 Dec; 48(6):718-22. PubMed ID: 63108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of fetal demise in advanced pregnancy terminations: report on a funic potassium chloride protocol.
    Gill P; Cyr D; Afrakhtah M; Mack L; Easterling T
    Fetal Diagn Ther; 1994; 9(4):278-82. PubMed ID: 7945911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mid-trimester termination of pregnancy--a randomised controlled trial of two prostaglandin regimens.
    Steyn DW; Pienaar MP
    S Afr Med J; 1993 Oct; 83(10):737-8. PubMed ID: 8191328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second and early third trimester pregnancy termination by extra-amniotic balloon and intracervical PGE2.
    Liu HS; Yu MH; Chang YK; Chu TY
    Int J Gynaecol Obstet; 1998 Jan; 60(1):29-34. PubMed ID: 9506411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Termination of second-trimester intrauterine fetal demise with prostaglandins.
    Thiery M; Parewijck W
    Contracept Deliv Syst; 1983 Apr; 4(2):89-100. PubMed ID: 12338638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second trimester pregnancy termination in primigravidas by double application of dinoprostone gel and intramuscular administration of carboprost tromethamine.
    Vukelić J
    Med Pregl; 2001; 54(1-2):11-6. PubMed ID: 11436877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of Foley's catheter and prostaglandin F-2 alpha in second trimester termination of pregnancy.
    Islam A; Abbasi Au; Sarwar I
    J Ayub Med Coll Abbottabad; 2006; 18(3):35-9. PubMed ID: 17348310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Induction of second trimester abortion by infusion of intraamniotic hypertonic and extraamniotic physiological saline solution (author's transl)].
    Blum M; Halbrecht I
    Geburtshilfe Frauenheilkd; 1976 May; 36(5):444-7. PubMed ID: 945209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy.
    Su LL; Biswas A; Choolani M; Kalaichelvan V; Singh K
    Am J Obstet Gynecol; 2005 Oct; 193(4):1410-4. PubMed ID: 16202734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone changes in relation to the time of fetal death after prostaglandin-induced abortion.
    Fraser IS; Nicholson KM; Graham G; Boyle H
    Prostaglandins; 1977 Jun; 13(6):1161-7. PubMed ID: 887804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion.
    Perni SC; Vardhana S; Tuttle SL; Kalish RB; Chasen ST; Witkin SS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1318-23. PubMed ID: 15507960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cortisol in amniotic fluid during PGE2-induced labor].
    Leszczyńska-Gorzelak B; Jakimiuk A; Oleszczuk J
    Zentralbl Gynakol; 1993; 115(12):550-2. PubMed ID: 8147168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
    Jansen NE; Pasker-De Jong PC; Zondervan HA
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Abortion in the 2d trimester by extra-amniotic infusion. Description of 149 cases].
    Blum M
    Minerva Ginecol; 1981; 33(2-3):253-6. PubMed ID: 7254656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.